Literature DB >> 15123774

Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines.

Gonzalo Rubio1, Xavier Férez, María Sánchez-Campillo, Jesús Gálvez, Salvador Martí, Rocío Verdú, Trinidad Hernández-Caselles, Pilar García-Peñarrubia.   

Abstract

Engagement of major histocompatibility complex (MHC) class I molecules on immune cells, where they are usually highly expressed, induces signal transduction events of unclear significance. We show here that antibody-mediated cross-linking of MHC-I molecules on human natural killer (NK) cells inhibits their cytotoxic activity against tumor target cells. Inhibition by anti-MHC class I monoclonal antibody exhibits molecular specificity and is an isotype and Fc-independent process. Physical hindrance of specific molecular recognition, induction of apoptosis, or reciprocal NK cell killing, which could be induced by cross-linking of MHC I molecules, has also been ruled out as putative mechanisms of inhibition. Confocal microscopy analysis revealed that MHC class I molecules on the surface of NK cells colocalize constitutively with GM1, a marker of lipid rafts. Cross-linking of MHC class I resulted in the asymmetric redistribution of GM1-enriched raft domains, which are concentrated to the immunological synapse, and MHC I molecules, which segregate to the opposite pole. Also, the cross-linking of MHC I on NK cells induced intracellular tyrosine phosphorylations. These results suggest that MHC I molecules on NK cells could transmit inhibitory signals upon engagement with putative ligands expressed on the surface of those cells that need to be protected from natural cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123774     DOI: 10.1189/jlb.1103597

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

2.  Mathematical modelling and computational study of two-dimensional and three-dimensional dynamics of receptor-ligand interactions in signalling response mechanisms.

Authors:  Pilar García-Peñarrubia; Juan J Gálvez; Jesús Gálvez
Journal:  J Math Biol       Date:  2013-07-28       Impact factor: 2.259

3.  Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Transplant Rep       Date:  2015-05-24

4.  Regulation of MHC class I expression by Foxp3 and its effect on regulatory T cell function.

Authors:  Jie Mu; Xuguang Tai; Shankar S Iyer; Jocelyn D Weissman; Alfred Singer; Dinah S Singer
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

Review 5.  Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.

Authors:  Elke M Muntjewerff; Luca D Meesters; Geert van den Bogaart; Natalia H Revelo
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

6.  Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.

Authors:  Andrea Ziblat; Ximena Lucía Raffo Iraolagoitia; Sol Yanel Nuñez; Nicolás Ignacio Torres; Florencia Secchiari; Jessica Mariel Sierra; Raúl Germán Spallanzani; Agustín Rovegno; Fernando Pablo Secin; Mercedes Beatriz Fuertes; Carolina Inés Domaica; Norberto Walter Zwirner
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

7.  MHC-I molecules selectively inhibit cell-mediated cytotoxicity triggered by ITAM-coupled activating receptors and 2B4.

Authors:  Rubén Corral-San Miguel; Trinidad Hernández-Caselles; Antonio José Ruiz Alcaraz; María Martínez-Esparza; Pilar García-Peñarrubia
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

8.  Receptor Crosslinking: A General Method to Trigger Internalization and Lysosomal Targeting of Therapeutic Receptor:Ligand Complexes.

Authors:  Paul R Moody; Edward J Sayers; Johannes P Magnusson; Cameron Alexander; Paola Borri; Peter Watson; Arwyn T Jones
Journal:  Mol Ther       Date:  2015-09-28       Impact factor: 11.454

9.  MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling.

Authors:  Simo Xia; Yijie Tao; Likun Cui; Yizhi Yu; Sheng Xu
Journal:  J Immunol Res       Date:  2019-09-09       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.